This company seems to have been delisted
Reason: Acquired by Ipsen
Last recorded trade on: October 14, 2022
Source: https://www.ipsen.com/press-releases/ipsen-to-acquire-epizyme-expanding-its-portfolio-in-oncology/
Reason: Acquired by Ipsen
Last recorded trade on: October 14, 2022
Source: https://www.ipsen.com/press-releases/ipsen-to-acquire-epizyme-expanding-its-portfolio-in-oncology/
Epizyme
EPZM
$2.63
Share price
0.00%
Change (1 day)
-62.92%
Change (1 year)
Categories
Earnings for Epizyme (EPZM)
Earnings in 2022 (TTM): -NZ$0.31 Billion
According to Epizyme's latest financial reports the company's current earnings are NZ$53 Million. In 2021 the company made an earning of -NZ$0.41 Billion a decrease over its 2020 earnings that were of -NZ$0.41 Billion.
Earnings history for Epizyme from 2012 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 (TTM) | -NZ$0.31 Billion | -24.38% |
| 2021 | -NZ$0.41 Billion | 0.63% |
| 2020 | -NZ$0.41 Billion | 32.62% |
| 2019 | -NZ$0.31 Billion | 32.74% |
| 2018 | -NZ$0.23 Billion | -6.38% |
| 2017 | -NZ$0.25 Billion | 22.37% |
| 2016 | -NZ$0.2 Billion | -15.63% |
| 2015 | -NZ$0.24 Billion | 140.78% |
| 2014 | -NZ$98.36 Million | 1660.47% |
| 2013 | -NZ$5.59 Million | 307.16% |
| 2012 | -NZ$1.38 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | -NZ$1.42 Billion | 330.61% | 🇺🇸 USA |
 | NZ$24.37 B | -7,529.44% | 🇨🇭 Switzerland |
 | NZ$7.85 B | -2,493.62% | 🇬🇧 UK |
 | NZ$12.53 B | -3,919.84% | 🇺🇸 USA |